Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Pharmacol Ther. 2020 May 29;213:107591. doi: 10.1016/j.pharmthera.2020.107591

Figure 2. The mechanisms of how LINK-A regulates antigen processing machinery.

Figure 2.

LINK-A-facilitated, TRIM71-mediated downregulation of antigen presentation machinery impairs antigen presentation during tumor initiation.